Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 30, 1998

View Archived Issues

Council Of State Freezes Transgenic Plant Ruling

Synaptic Weight Theory Regains Respect Through New Saturation Experiment

British Biotech Managers Step Down At Meeting

Irish BioVentures Hoping To Bridge Research, Finance

Biota's Influenza Drug Shows Positive Results

Core Group Losses Up; On Plan, Company Says

D-Pharm Buys Lipid 'Tag' Rights From Oregon Firm

Chiroscience Group Aims At Profitability In 2001

Metabolic Pharmaceuticals Works On Anti-Fat Drug

Biovector, Biomira Sign $16M Deal For Lymphoma Vaccine

Trinity Biotech Acquires FDA-OK'd Cardiac Test

Visible Genetics Study Tests HIV Genotyping

Oxford Reports Losses Up; Deals Promise More Cash

A Message To BioWorld Subscribers About Copyright Law

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...